in this issue
Regions :: North America :: Canada
Mitsubishi Chemical completes acquisition of Medicago
12:05 AM MDT | September 20, 2013 | Deepti Ramesh
Mitsubishi Chemical Holdings says that its Mitsubishi Tanabe Pharma (Osaka) subsidiary has completed the previously announced acquisition of Canadian pharmaceutical company Medicago (Quebec City). Medicago will be operated as a joint venture owned 60% by Mitsubishi Tanabe Pharma and 40% by Philip Morris Investments (Bergen op Zoom, Netherlands). Medicago is a clinical-stage biopharmaceutical company that develops vaccines and therapeutic proteins to address a range of infectious diseases. Shares of Medicago were delisted from trading on the Tokyo Stock Exchange...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee